carbon monoxide has been researched along with varenicline in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 14 (70.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glaser, PE; Rush, CR; Stoops, WW; Vansickel, AR | 1 |
| Hering, T | 1 |
| Arteaga, C; Brandon, TH; Gonzales, D; Jorenby, DE; Lee, TC | 1 |
| Jao, NC; Karelitz, JL; Perkins, KA | 1 |
| Davis, R; Kmetova, A; Kralikova, E; Stepankova, L; West, R; Zvolska, K | 1 |
| Anderson, BJ; Audet, D; Caviness, CM; Kurth, ME; Olson, J; Stein, MD | 1 |
| Pezzuto, A; Spoto, C; Tonini, G; Vincenzi, B | 1 |
| Abdool-Gaffar, MS; Bateman, ED; Bruning, A; Emanuel, S; Esterhuizen, TM; Irusen, EM; Koegelenberg, CF; Noor, F; O'Brien, JA; Smith, C; van Zyl-Smit, RN | 1 |
| Baker, TB; Bolt, DM; Fiore, MC; Fraser, DL; Piper, ME; Smith, SS; Stein, JH | 1 |
| Jeon, DW; Jung, DU; Kim, SJ; Kong, BG; Moon, JJ; Oh, MK; Seo, YS; Shim, JC | 1 |
| Iwaoka, M; Tsuji, T | 1 |
| Andreadou, I; Ikonomidis, I; Kourea, K; Lekakis, J; Liarakos, N; Marinou, M; Parissis, J; Pavlidis, G; Triantafyllidi, H; Tsougos, E; Vlastos, D | 1 |
| Boffi, R; Colombo, F; Galvan, A; Noci, S; Pasetti, G; Pastorino, U; Pintarelli, G; Pozzi, P; Sala, F | 1 |
| Esterhuizen, TM; Irusen, EM; Koegelenberg, CFN; Noor, F | 1 |
| Cazzola, M; Hernández Zenteno, RJ; Lara, DF; Matera, MG; Pérez Padilla, JR; Pineda, JR; Sansores, RH; Trujillo, FF; Venegas, AR | 1 |
| Cornuz, J; Csajka, C; Dobrinas, M; Eap, CB; Glatard, A; Guidi, M | 1 |
| Carico, E; Pezzuto, A | 1 |
| Baker, TB; Bolt, DM; Fiore, MC; Piper, ME; Smith, SS; Stein, JH | 1 |
| Chami, HA; Makki, M; Shaya, M; Talih, F; Tamim, H; Zaouk, N | 1 |
| Kato, T; Kotani, K; Miyagawa, K; Mochida, A; Ohira, Y; Okada, Y; Takeda, H; Umeda, A | 1 |
12 trial(s) available for carbon monoxide and varenicline
| Article | Year |
|---|---|
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
Topics: Adolescent; Adult; Aged; Benzazepines; Breath Tests; Bupropion; Carbon Monoxide; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Drug Labeling; Female; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Male; Middle Aged; Motivation; Nicotinic Agonists; Placebos; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Varenicline; Young Adult | 2010 |
Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence.
Topics: Adult; Benzazepines; Carbon Monoxide; Cross-Over Studies; Female; Humans; Male; Nicotinic Agonists; Prospective Studies; Quinoxalines; Reward; Sensitivity and Specificity; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Products; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2013 |
Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.
Topics: Adult; Benzazepines; Carbon Monoxide; Female; Follow-Up Studies; Guideline Adherence; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Patient Compliance; Quinoxalines; Smoking Cessation; Socioeconomic Factors; Tobacco Use Disorder; Varenicline | 2013 |
Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
Topics: Adult; Benzazepines; Breath Tests; Carbon Monoxide; Cholinergic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Topics: Adult; Carbon Monoxide; Counseling; Female; Humans; Intention to Treat Analysis; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices; Varenicline | 2016 |
Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: A randomized double-blind placebo-controlled trial.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Carbon Monoxide; Double-Blind Method; Female; Humans; Male; Nicotinic Agonists; Schizophrenia; Severity of Illness Index; Smoking Reduction; Treatment Outcome; Varenicline | 2016 |
Twelve Weeks of Successful Smoking Cessation Therapy with Varenicline Reduces Spirometric Lung Age.
Topics: Adult; Carbon Monoxide; Female; Humans; Lung; Male; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; Spirometry; Time Factors; Treatment Outcome; Varenicline | 2016 |
Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program.
Topics: Adult; Aged; Breath Tests; Carbon Monoxide; Endothelial Cells; Female; Glycocalyx; Greece; Humans; Male; Malondialdehyde; Middle Aged; Nicotinic Agonists; Oxidative Stress; Protein Carbonylation; Pulse Wave Analysis; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline; Vascular Stiffness | 2017 |
Predictors of treatment success in smoking cessation with varenicline combined with nicotine replacement therapy v. varenicline alone.
Topics: Adult; Age Factors; Breath Tests; Carbon Monoxide; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Predictive Value of Tests; Smoking; Smoking Cessation; South Africa; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2017 |
Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population.
Topics: Adult; Body Weight; Carbon Monoxide; Dose-Response Relationship, Drug; Female; Genotype; Glucuronosyltransferase; Humans; Male; Middle Aged; Models, Biological; Polymorphism, Single Nucleotide; Smokers; Smoking Cessation; Smoking Cessation Agents; Varenicline; Young Adult | 2019 |
Effects of Combined Varenicline With Nicotine Patch and of Extended Treatment Duration on Smoking Cessation: A Randomized Clinical Trial.
Topics: Carbon Monoxide; Combined Modality Therapy; Confidence Intervals; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Nicotinic Agonists; Odds Ratio; Placebos; Self Report; Sleep Initiation and Maintenance Disorders; Smoking Cessation; Temperance; Time Factors; Tobacco Use Cessation Devices; Varenicline; Wisconsin | 2021 |
Varenicline Treatment for Waterpipe Smoking Cessation.
Topics: Adult; Carbon Monoxide; Cotinine; Female; Humans; Male; Nicotinic Agonists; Smoking Cessation; Varenicline; Water Pipe Smoking | 2023 |
8 other study(ies) available for carbon monoxide and varenicline
| Article | Year |
|---|---|
The influence of acute varenicline administration on smoking and eating behavior in humans.
Topics: Adult; Benzazepines; Carbon Monoxide; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Feeding Behavior; Female; Humans; Male; Methylphenidate; Quinoxalines; Smoking; Surveys and Questionnaires; Varenicline | 2008 |
[Specific program for smoking cessation: thus your patients become nonsmokers].
Topics: Behavior Therapy; Benzazepines; Bupropion; Carbon Monoxide; Contraindications; Humans; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy.
Topics: Benzazepines; Breath Tests; Carbon Monoxide; Drug Administration Routes; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level.
Topics: Benzazepines; Carbon Monoxide; Carboxyhemoglobin; Carcinoembryonic Antigen; Combined Modality Therapy; Cough; Counseling; Dyspnea; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Vital Capacity | 2013 |
Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
Topics: 5' Untranslated Regions; Adult; Aged; Bupropion; Carbon Monoxide; Exhalation; Female; Humans; Male; Middle Aged; Nerve Tissue Proteins; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2017 |
Varenicline for long term smoking cessation in patients with COPD.
Topics: Adult; Airway Obstruction; Carbon Monoxide; Cohort Studies; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2018 |
Effectiveness of smoking cessation in smokers with COPD and nocturnal oxygen desaturation: Functional analysis.
Topics: Adult; Blood Gas Analysis; Carbon Monoxide; Case-Control Studies; Exhalation; Female; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Oximetry; Oxygen; Plethysmography; Predictive Value of Tests; Program Evaluation; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Retrospective Studies; Sleep Apnea Syndromes; Smokers; Smoking Cessation; Smoking Cessation Agents; Time Factors; Varenicline; Walk Test | 2020 |
Effects of smoking cessation using varenicline on the serum concentrations of oxidized high-density lipoprotein: Comparison with high-density lipoprotein cholesterol.
Topics: Adult; Carbon Monoxide; Cholesterol, HDL; Humans; Lipoproteins, HDL; Smoking; Smoking Cessation; Varenicline | 2022 |